Trading on December 31 at the American stock markets ended in the green zone. The S&P 500 index climbed 0.64% to 3756 points, the Dow
Mereo BioPharma Group plc (MREO) stock plunged -7.78% to $3.32 in the pre-market trading after declaring collaboration and license agreement with Ultragenyx Pharmaceutical Inc. (RARE),
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.